Prosecution Insights
Last updated: April 19, 2026

Examiner: HOLLOMAN, NANNETTE

Tech Center 1600 • Art Units: 1612 1699

This examiner grants 60% of resolved cases

Performance Statistics

60.3%
Allow Rate
At TC average
797
Total Applications
+22.9%
Interview Lift
1078
Avg Prosecution Days
Based on 778 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
18.9%
§102 Novelty
52.6%
§103 Obviousness
18.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19339197 STRUCTURALLY DIVERSE, STABLE, AND RADIATION-PROTECTIVE PARTICLE MATRIX SUNSCREEN AND COSMETIC COMPOSITIONS AND RELATED METHODS Non-Final OA LCS Advanced Solutions, LLC
18256310 IMPROVE THE WATER RESISTANCE OF COSMETIC COMPOSITIONS COMPRISING BISOCTRIZOLE Non-Final OA DSM IP ASSETS B.V.
19287933 METHODS AND COMPOSITIONS TO INCREASE HAIR GROWTH AND/OR PREVENT HAIR LOSS Non-Final OA ATTAIN HEALTH INC.
17890533 Oral Care Compositions For Gum Health Non-Final OA The Procter & Gamble Company
18436344 Oral Care Compositions Non-Final OA Colgate-Palmolive Company
18566904 NANOVESICLE REACTOR AND MANUFACTURING METHOD THEREFOR Non-Final OA Ulsan National Institute of Science and Technology
18693579 POLYACRYLAMIDE HYDROGEL FOR USE IN THE TREATMENT AND/OR PREVENTION OF OSTEOARTHRITIS Non-Final OA CONTURA INTERNATIONAL A/S
18529036 COSMETIC SUNSCREEN WITH HIGH WET SKIN UV PROTECTION Non-Final OA BEIERSDORF AG
18579824 METHODS FOR PREPARING LIPOSOMAL FORMULATIONS Non-Final OA Jazz Pharmaceuticals Therapeutics, Inc.
18577390 FORMULATIONS FOR THE TREATMENT OF RESPIRATORY DISORDERS Non-Final OA 484 Science Corp
18058557 MACROSCOPIC SOLAR DISPERSION WITHOUT SHELL Non-Final OA CAPSUM
17923618 NUTRACEUTICAL COMPOSITION AND METHOD OF PRODUCTION THEREOF Non-Final OA Indian Institute of Technology Bombay
17997598 NANOSTRUCTURED HYBRID MATERIAL BASED ON NIOBIUM OLIGOMERS, OBTENTION METHOD, AND USE Non-Final OA ODONTO TECH PESQUISA E INOVACAO LTDA
17596518 COMPOSITIONS FOR CLEANSING REMOVABLE DENTAL PROSTHETICS Final Rejection Armis Biopharma, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month